664
panel
How Asia Leads on FinTech: A Discussion with Industry Leaders (Invite only)
Nowhere in the world has the pace of FinTech innovation, growth, and adoption been as rapid as i
t is in Asia.
+ Read More
panel
Untying the Invisible Hand in Biomedical R&D (Invite only)
A tighter reimbursement environment has heightened a need for efficiency and resulted in greater
specialization in biopharmaceutical R&D—and more and more pipeline cuts to focus on the best investments.
+ Read More
panel
Sports Ownership: The Investment Case (Invite only)
Over the past 10 years, professional sports franchises have seen an unprecedented increase in va
luation. NFL team valuations have risen almost 10 times in 20 years, while NBA team valuations have increased over 300 percent in the past five years alone.
+ Read More
panel
Achieving Social Impact Through Opportunity Zones (Invite only)
Opportunity Zones are an innovative way to address the lack of access to capital in low-income c
ommunities nationally.
+ Read More
panel
DevTech: Meeting SDGs through Disruptive Technologies (Invite only)
Given the demographic destinies shaping global aggregate demand and productivity, emerging and f
rontier markets offer the greatest promise to become sustainable global growth drivers.
+ Read More
panel
The Rise of Private Markets (Invite only)
Following up on the session that took place at the Asia Summit, this roundtable on employing a l
onger-term focus in business and investment decision-making will convene leading asset owners and investors who are thoughtful above and beyond their own por
+ Read More
panel
Beyond Crypto's Wild Ride
Both the promise and peril of investing in cryptocurrencies has been amply demonstrated over the
last year, but beyond the headline-making proliferation of crypto coins and the general volatility of the asset class, the crypto ecosystem as a whole has m
+ Read More
panel
Can Health Data Fuel Global Collaboration for Cures?
Data is the currency that powers all sectors of economy. Nowhere is this truer than in the area
of biomedical research—a key driver of economic growth and competition.
+ Read More
panel
Common Sense from Uncommon Investors
Join Chairman Mike Milken as he sits down with some of the founders who have shaped financial ma
rkets for decades.
+ Read More
panel
Food as Medicine
As more medical professionals continue to advocate for nutritional changes to assist in treating
diabetes, hypertension, and even cancer, we need to explore ways to bring the idea of food as medicine to the forefront of disease treatment.
+ Read More
panel